INTELLIGENT FAULT TOLERANT
DEAD

Serial Number

90687741

Owner

Essenlix Corporation

Attorney

Julian Gonzalez

Filing Date

May 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INTELLIGENT FAULT TOLERANT Trademark

Serial Number: 90687741

INTELLIGENT FAULT TOLERANT is a trademark filed by Essenlix Corporation on May 3, 2021. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Essenlix Corporation (148 trademarks)

7 Foulet Dr
Princeton, CA 08540

Entity Type: 03

Trademark Details

Filing Date

May 3, 2021

Registration Date

Not Registered

Goods & Services

Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the nature of providing information in the fields of health and wellness; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes

Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids in the nature of biological and chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 6, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 6, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 6, 2023 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 19, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 19, 2022 GNFR
FINAL REFUSAL WRITTEN
Aug 19, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 4, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2021 NWOS
NEW APPLICATION ENTERED
May 6, 2021 NWAP